VANCOUVER, Jan. 7 /CNW/ - Prescient Neuropharma Inc. (the "Company")
reports that pursuant to the Company's Stock Option Plan, a total of 4,200,000
stock options have been re-priced to $0.10 per share. All other original terms
pertaining to the option agreements will remain unchanged.
850,000 of the options are issued to insiders of the Company and will be
subject to regulatory and disinterested shareholder approval.
On behalf of Prescient Neuropharma Inc.
President and Director
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the
content of this news release.
For further information:
For further information: Gordon Keep, President, Tel: (604) 609-6110